Scarica l'app Stockscreener
8.48
4.83%
-0.43
Dopo l'orario di chiusura:
8.50
0.02
+0.24%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NVAX Giù?
Forum
Previsione
Frazionamento azionario
Novavax Inc Borsa (NVAX) Ultime notizie
Novavax (NVAX) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
Automated trading signals detected on Novavax Inc.Share Buyback & Real-Time Buy Signal Notifications - newser.com
What drives Novavax Inc stock priceVolatility Adjusted Trading & Free Dynamic Capital Growth - earlytimes.in
Novavax told by FDA to conduct additional study for COVID vaccinereport - MSN
Can Novavax’s Valuation Shift After Shah Capital Pushes for Company Sale? - Yahoo Finance
How Novavax Inc. stock compares to market leadersRisk Management & Free Community Consensus Stock Picks - newser.com
Intraday pattern recognizer results for Novavax Inc.July 2025 Breakouts & Expert Approved Momentum Trade Ideas - newser.com
Can Novavax Inc. stock sustain market leadershipShort Setup & Real-Time Chart Breakout Alerts - newser.com
Novavax Activist Investor Returns, This Time Pushing For Exit Strategy - insights.citeline.com
Top Novavax Shareholder Demands Company’s Sale - Barron's
Hedge Fund Shah Capital Urges Novavax To Consider Sale Amid Vaccine Rollout Struggles, Sees $5 Billion Potential - inkl
Shah Capital pushes for Novavax's sale on persistent underperformance, marketing missteps - Reuters
Shah Capital urges sale of Novavax amid continued vaccine sales struggles - The American Bazaar
Shah Capital Sends Letter to Novavax - MarketScreener
Novavax stock rises after major shareholder urges company sale By Investing.com - Investing.com Australia
Novavax stock rises after major shareholder urges company sale - Investing.com
Shah Capital Urges Sale of Novavax (NVAX) Amid COVID-19 Vaccine Struggles - GuruFocus
Novavax shareholder Shah Capital urges vaccine maker to explore sale amid market struggles - The Business Journals
Novavax top investor urges sale over poor COVID shot rollout; shares rise - TradingView
Shah Capital Pushes for Novavax (NVAX) Strategic Overhaul - GuruFocus
Novavax shareholder with large stake asks company to consider selling itself - Seeking Alpha
Investor seeks sale of Novavax after poor COVID jab sales - pharmaphorum
Novavax falls as top investor urges sale over poor COVID shot rollout - TradingView
Shah Capital recommends immediate formal strategic review for sale of Novavax - MarketScreener
New US COVID guidelines add confusion, complications for Americans seeking shots - MarketScreener
Will Novavax Inc. (NVV1) stock benefit from sector leadershipTrade Ideas & AI Enhanced Trading Signals - newser.com
Is Novavax Inc. stock attractive for retirement portfoliosBond Market & Real-Time Stock Entry Alerts - newser.com
Analyzing recovery setups for Novavax Inc. investors2025 Short Interest & High Accuracy Trade Signal Alerts - newser.com
Tools to assess Novavax Inc.’s risk profileRecession Risk & Fast Entry Momentum Trade Alerts - newser.com
What analysts say about Novavax Inc NVV1 stockSwing Trading Watchlist & High Profit Growth Stocks - earlytimes.in
Novavax Inc. Stock Underperforms Thursday When Compared To Competitors - 富途牛牛
Novavax starts late-stage trial of COVID-19 vaccine in United States - Reuters
Novavax Inc. Stock Underperforms Friday When Compared To Competitors - 富途牛牛
Will Novavax Inc. continue its uptrendPortfolio Return Summary & Expert Approved Momentum Trade Ideas - newser.com
Statistical indicators supporting Novavax Inc.’s strengthJuly 2025 Analyst Calls & Real-Time Volume Spike Alerts - newser.com
Analyzing Novavax Inc. with risk reward ratio chartsTrade Ideas & Long-Term Investment Growth Plans - newser.com
Is Novavax Inc. stock attractive after correctionWeekly Volume Report & Weekly High Conviction Ideas - newser.com
Is Novavax Inc. (NVV1) stock a buy on weakness2025 Pullback Review & Scalable Portfolio Growth Methods - newser.com
Is Novavax Inc. showing signs of accumulationMarket Performance Summary & Reliable Volume Spike Trade Alerts - newser.com
What institutional flow reveals about Novavax Inc.July 2025 Final Week & Fast Gain Stock Tips - newser.com
Novavax Inc Completes EU Marketing Authorization Transfer for Nuvaxovid - TradingView
Novavax Inc. Stock Slides 3.5%, Underperforms Peers - 富途牛牛
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know - Yahoo Finance
Novavax, Inc. Experiences Evaluation Revision Amid Mixed Market Performance Indicators - Markets Mojo
Novavax (NVAX) Transfers EU Vaccine Rights to Sanofi for $25M - GuruFocus
Shah Capital Management Has $72.52 Million Stock Position in Novavax, Inc. $NVAX - MarketBeat
Novavax hands over Nuvaxovid marketing rights to Sanofi in the EU - Seeking Alpha
Novavax Continues to Deliver on Sanofi Partnership, Completion Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone Payment - MarketScreener
Novavax Completes Transfer of Marketing Authorization for COVID-19 Vaccine in EU to Sanofi - MarketScreener
Sanofi (SNY) Gains Full EU Control of Nuvaxovid from Novavax - GuruFocus
Novavax receives $25 million milestone payment from Sanofi partnership - Investing.com
Novavax Transfers EU Vaccine Rights to Sanofi - TipRanks
$25M Milestone: Novavax Transfers Nuvaxovid EU Authorization to Sanofi; Eligible for Up to $350M - Stock Titan
Novavax Continues to Deliver on Sanofi Partnership, Completing Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone Payment - Sahm
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):